Compare OFIX & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OFIX | RGR |
|---|---|---|
| Founded | 1987 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 473.3M | 521.9M |
| IPO Year | 1998 | 1994 |
| Metric | OFIX | RGR |
|---|---|---|
| Price | $12.71 | $42.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $17.25 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 225.6K | 160.0K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.09% |
| EPS Growth | ★ 29.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $822,312,000.00 | $546,057,000.00 |
| Revenue This Year | $6.10 | $2.38 |
| Revenue Next Year | $6.24 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2.85 | 1.94 |
| 52 Week Low | $10.25 | $28.33 |
| 52 Week High | $16.99 | $48.21 |
| Indicator | OFIX | RGR |
|---|---|---|
| Relative Strength Index (RSI) | 57.68 | 60.28 |
| Support Level | $12.33 | $36.28 |
| Resistance Level | $16.38 | $44.10 |
| Average True Range (ATR) | 0.40 | 1.15 |
| MACD | 0.18 | 0.04 |
| Stochastic Oscillator | 81.72 | 81.42 |
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.